DOCEBO INC (DCBO.US) is offering to purchase Ordinary Shares, of the Company that are issued and outstanding at a price of $55.00 per common share, net to the seller in cash, without interest, less any applicable withholding taxes.
Participants are advised that this offer has the following feature:
ODD LOT PREFERENCE: a holder´s entire position must be tendered. Participants entering instructions on behalf of beneficial holders of 99 shares or less, if accepted, will be exempt from any prorated acceptance.
The terms of the offer are as follows:
Option (1): Take no action [Default option]
Option (2): Tender Shares – PRICE OF USD 55.00 PER SHARE IN NET CASH (without interest, less any applicable withholding taxes, subject to proration.）
The deadline to tender shares to the offer will be 20/12/2023@ 16:00 (HONG KONG TIME GMT+8).
In the absence of an election, no action will be taken.
Please fill in the following information and use the registered email address of Futu to send an email to cs@futuhk.com.
1. Account Number:
2. Name: (In Chinese or English)
3. Stock code: DCBO.US
4. Options: (1) or (2)
5. Number of shares participating in corporate actions:
Note to applicants:
1. For shareholders holding less than 1 share of DCBO.US, they cannot participate in related corporate actions.
2. Option (1) is the default option. We will help clients to choose option (1) if have not received clients’ emails.
3. Once the relevant application is submitted, the stocks participating in the company's actions cannot be traded and the application cannot be withdrawn.
4. This corporate action does not accept additional applications, the maximum number of applications that a client can apply for does not exceed the number of eligible shares it holds.
5. The pending orders and unsettled shares will not be accepted for the time being.
6. Please confirm that the account funds are sufficient to pay the relevant fees of this corporate action. Otherwise, we will not bear any responsibility for the failure of your application.
7. If there is any update, all the information released by the listed company shall prevail.
